Citation Impact
Citing Papers
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Targeting Wnt pathway in mantle cell lymphoma-initiating cells
2015
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers
2016
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
2010 Standout
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
2017 Standout
Downregulation of miR-200a Induces EMT Phenotypes and CSC-like Signatures through Targeting the β-catenin Pathway in Hepatic Oval Cells
2013
Curcumin, the Golden Spice From Indian Saffron, Is a Chemosensitizer and Radiosensitizer for Tumors and Chemoprotector and Radioprotector for Normal Organs
2010 Standout
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
2012 Standout
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
2009 StandoutNature
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria
2012 Nature
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3
2011
Biology of interleukin-22
2010
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia
2007
Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization
2019 StandoutNobel
The role of the IL-22/IL-22R1 axis in cancer
2014
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Maternal and neonatal tetanus
2007
Drug repurposing: progress, challenges and recommendations
2018 Standout
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000
2012 Standout
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens
2004
Interleukin (IL)-21 promotes intestinal IgA response to microbiota
2015
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid
2013
Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1α-induced metabolic reprograming
2010
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
2006
Molecular pathogenesis of mantle cell lymphoma
2012
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
A novel role for IL-22R1 as a driver of inflammation
2010
Hypoxia-Inducible Factor 1 and Cardiovascular Disease
2013 StandoutNobel
Research confuses me: what is the difference between case-control and cohort studies in quantitative research?
2013 Standout
The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age.
1985
SGX393 inhibits the CML mutant Bcr-Abl T315I and preempts in vitro resistance when combined with nilotinib or dasatinib
2008
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)
2011
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
2011 Standout
Works of Mona Anand being referenced
Interleukin 22 Signaling Promotes Cell Growth in Mantle Cell Lymphoma
2011
-catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma
2010
The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib
2006
Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma
2008
IL-21 Contributes to JAK3/STAT3 Activation and Promotes Cell Growth in ALK-Positive Anaplastic Large Cell Lymphoma
2009
Disheveled proteins promote cell growth and tumorigenicity in ALK-positive anaplastic large cell lymphoma
2012
Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma
2008
RESPONSE TO SINGLE DOSE OF TETANUS VACCINE IN SUBJECTS WITH NATURALLY ACQUIRED TETANUS ANTITOXIN
1981
In vivo kinetics of kinase domain mutations in CML patients treated with dasatinib after failing imatinib
2007